FDA Approved: BICILLIN L-A — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approves a supplemental application for Bicillin L-A (penicillin G benzathine) from Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Fever Prophylaxis
• Streptococcal Infection
• Syphilis

Drugs mentioned

• BICILLIN L-A (PENICILLIN G BENZATHINE)

Snippet

SUPPL AP for BICILLIN L-A (PENICILLIN G BENZATHINE)